About Us
Investors
TRC Technology
Clinical Programs
News
Careers
Contact
Corporate Overview
Aastrom Advantages
Management Team & Directors
Financial Information
Stock Information
Shareholder Services
Corporate Governance
Cell Manufacturing
Understanding Stem Cells
Intellectual Property
Cardiac Regeneration
Vascular Regeneration
Bone Regeneration
Publications
Press Releases
Aastrom in the News
Register for Email
Calendar of Events
Print page
|
Email page
Investor Presentation
Fact Sheet
Financial Information
Quarterly Results
Annual Reports/Proxy
SEC Filings
Financial News
Stock Information
Stock Performance
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Shareholder Services
Investor FAQs
Shareholder Electronic Delivery
Contact Us
Corporate Governance
Board of Directors
Committees & Charters
Insider Transactions
Insider Ownership
Investor Relations
SEC Filings
View:
All Filings
Annual
Quarterly
Current
Section 16
Proxy
Year:
All Years
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
= Add Filing to Briefcase
Filing
Description
Date Filed
Size
8-K
current report
01-27-10
228.1 KB
8-K
current report
01-15-10
296.1 KB
424B5
prospectus filed pursuant to rule 424
01-15-10
409.1 KB
424B5
prospectus filed pursuant to rule 424
01-14-10
409.2 KB
8-K
current report
01-08-10
1.6 MB
S-8
registration statement
12-18-09
67.2 KB
8-K
current report
12-17-09
31.1 KB
4
dunbar, george w jr
12-16-09
26.2 KB
4
mayleben, timothy m
12-16-09
26.1 KB
4
sims, nelson m
12-16-09
25.7 KB
4
urschel, harold c jr
12-16-09
25.9 KB
4
zerbe, robert l md
12-16-09
25.7 KB
4
rubino, alan l
12-16-09
25.7 KB
DEFA14A
definitive proxy statement
12-09-09
27.9 KB
10-Q
quarterly report
11-06-09
362.3 KB
8-K
current report
11-06-09
68.9 KB
DEF 14A
definitive proxy statement
10-27-09
516.6 KB
8-K
current report
10-27-09
145.8 KB
4
urschel, harold c jr
10-20-09
27.7 KB
3
urschel harold c jr
10-20-09
24.5 KB
Showing 1-20 of 491 filings
Page: 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
See Next 20
Stock Information
ASTM - (NASDAQ)
$0.21
- 0.01
02-08-10
3:59 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Shareholder Tools
Investor Briefcase
Investor Kit
News/Event Alerts
Download Library
News Feeds
Home
|
Forward Looking Statement
Aastrom Biosciences, Inc. · Tel: 734-930-5555 © 2010